Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histamine H3 receptor agonists.

I J P De Esch1, K J Belzar

  • 1De Novo Pharmaceuticals, Compass House, Vision Park Histon, Cambridge, UK. ideesch@few.vu.nl

Mini Reviews in Medicinal Chemistry
|November 17, 2004
PubMed
Summary

Evaluating the structure-activity relationship (SAR) of Histamine H3 receptor (H3R) ligands is challenging due to species variations and other factors. This review consolidates conflicting affinity, activity, and efficacy data for H3R agonists from existing literature.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micro-foundations of dynamic capabilities to facilitate university technology transfer.

PloS one·2023
Same author

Career development in fragment-based drug discovery.

Drug discovery today. Technologies·2021
Same author

Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

European journal of medicinal chemistry·2018
Same author

C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions.

Drug discovery today. Technologies·2014
Same author

A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

British journal of pharmacology·2013
Same author

Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.

British journal of pharmacology·2013

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Neuroscience

Background:

  • The Histamine H3 receptor (H3R) is a G protein-coupled receptor involved in neurotransmission.
  • Understanding the structure-activity relationship (SAR) of H3R ligands is crucial for drug development.
  • Previous studies on H3R ligands have faced challenges including species differences, multiple receptor isoforms, and constitutive receptor activity.

Purpose of the Study:

  • To review and synthesize the available data on the affinity, activity, and efficacy of Histamine H3 receptor agonists.
  • To highlight the complexities and sometimes conflicting findings in the literature regarding H3R ligand pharmacology.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of reported affinity, activity, and efficacy data for H3R agonists.

Related Experiment Videos

  • Comparison of data across different species and experimental conditions.

    • Main Results:

    • Significant variability exists in reported affinity and efficacy data for H3R agonists.
    • Species differences in H3R orthologs contribute to discrepancies in ligand binding and function.
    • Constitutive activity of the H3R complicates the interpretation of agonist data.

    Conclusions:

    • The SAR of H3R ligands is complex and challenging to define definitively.
    • Further research is needed to reconcile conflicting data and establish reliable structure-activity relationships for H3R modulators.
    • Consistent methodologies and species-specific considerations are essential for future H3R drug discovery efforts.